Pharma

GSK to get 1 Billion Pound Boost in 2010 due to Swine Flu Medicine

GlaxoSmithKline is likely to get 1 billion pound revenue boost in 2010, as governments stockpile swine flu medicines designed to combat a possible pandemic.

GSK has 22 government contracts since last summer. Besides, due to higher demand, the company which makes the vaccine in Dresden and Quebec is outsourcing production to third-party manufacturers, the report said.

In the UK, there are plans to vaccinate the entire population if necessary, and the government has given the go-ahead for vulnerable people, such as pregnant women, frontline health workers and young children, to be inoculated.

GSK has been planning for a pandemic for three-and-a-half years and has spent more than 1 billion pound to ensure its factories could crank up production at short notice.

dIgitalhealth

Follow and connect with us on Facebook, Twitter, LinkedIn, Elets video

Eletsonline News

Follow us on


Most Popular

SUBSCRIBE OUR NEWSLETTER
200000+ Subscribers read it every day.
Subscribe Newsletter
To Top